Suppr超能文献

凝血因子 XIII 变体,其凝血酶激活速率发生改变。

Coagulation factor XIII variants with altered thrombin activation rates.

机构信息

Biopharmaceutical Research Unit, Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark.

出版信息

Biol Chem. 2009 Dec;390(12):1279-83. doi: 10.1515/BC.2009.142.

Abstract

Coagulation factor XIII (FXIII) is activated by thrombin and catalyses crosslinking between fibrin monomers thereby providing mechanical strength to the fibrin network. V34L is a common FXIII-A polymorphism found in the activation peptide. FXIII-A V34L is activated faster by thrombin and provides formation of a tighter clot at fibrinogen concentrations in the low end of the physiological range. FXIII-A variants with potentially increased activation rates were generated. Introduction of an optimal thrombin cleavage site, V34L+V35T, increased the activation rate 7.6-fold and facilitated the formation of a fibrin network more resistant to fibrinolysis than obtained with wt FXIII-A. In contrast, introduction of fragments of fibrinopeptide A into the activation peptide resulted in severely impaired activation rates.

摘要

凝血因子 XIII(FXIII)由凝血酶激活,并催化纤维蛋白单体之间的交联,从而为纤维蛋白网络提供机械强度。V34L 是激活肽中常见的 FXIII-A 多态性。FXIII-A V34L 被凝血酶更快地激活,并在纤维蛋白原浓度处于生理范围低端时形成更紧密的血栓。生成了潜在激活率增加的 FXIII-A 变体。引入最佳的凝血酶切割位点 V34L+V35T,将激活率提高了 7.6 倍,并使纤维蛋白网络的形成比 wt FXIII-A 更能抵抗纤维蛋白溶解。相比之下,将纤维蛋白肽 A 的片段引入激活肽会导致严重受损的激活率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验